Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cortina

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Benzimidazolone p38 inhibitorsMark A Dombroski, Michael A Letavic, Kim F McClure, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1Lawrence A Reiter, Ralph P Robinson, Kim F McClure, et al.
Journal of Medicinal Chemistry|September 2, 2005
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinaseKim F McClure, Yuriy A Abramov, Ellen R Laird, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical developmentKim F McClure, Michael A Letavic, Amit S Kalgutkar, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Benzimidazolone p38 inhibitorsMark A Dombroski, Michael A Letavic, Kim F McClure, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1Lawrence A Reiter, Ralph P Robinson, Kim F McClure, et al.
Journal of Medicinal Chemistry|September 2, 2005
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinaseKim F McClure, Yuriy A Abramov, Ellen R Laird, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical developmentKim F McClure, Michael A Letavic, Amit S Kalgutkar, et al.
Pageof 3